vs
Side-by-side financial comparison of Corteva (CTVA) and W. R. Berkley Corporation (WRB). Click either name above to swap in a different company.
Corteva is the larger business by last-quarter revenue ($4.9B vs $3.7B, roughly 1.3× W. R. Berkley Corporation). Corteva runs the higher net margin — 14.7% vs 14.0%, a 0.8% gap on every dollar of revenue. On growth, Corteva posted the faster year-over-year revenue change (11.0% vs 4.0%). Over the past eight quarters, W. R. Berkley Corporation's revenue compounded faster (5.5% CAGR vs -10.4%).
Corteva, Inc. is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals that are sold in 110 countries. The company's name combines "cor" with "teva". It is headquartered in Indianapolis, Indiana. Corteva sells a large portion of their seeds under the Pioneer Hi-Bred International brand.
William Robert Berkley is the founder and current chairman of W. R. Berkley Corporation and the chairman of the New York University Board of Trustees.
CTVA vs WRB — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $4.9B | $3.7B |
| Net Profit | $723.0M | $515.2M |
| Gross Margin | 51.6% | — |
| Operating Margin | — | — |
| Net Margin | 14.7% | 14.0% |
| Revenue YoY | 11.0% | 4.0% |
| Net Profit YoY | 10.4% | — |
| EPS (diluted) | $1.07 | $1.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $4.9B | $3.7B | ||
| Q4 25 | $3.9B | $3.7B | ||
| Q3 25 | $2.6B | $3.8B | ||
| Q2 25 | $6.5B | $3.7B | ||
| Q1 25 | $4.4B | $3.5B | ||
| Q4 24 | $4.0B | $3.7B | ||
| Q3 24 | $2.3B | $3.4B | ||
| Q2 24 | $6.1B | $3.3B |
| Q1 26 | $723.0M | $515.2M | ||
| Q4 25 | $-552.0M | $449.5M | ||
| Q3 25 | $-320.0M | $511.0M | ||
| Q2 25 | $1.3B | $401.3M | ||
| Q1 25 | $652.0M | $417.6M | ||
| Q4 24 | $-41.0M | $576.1M | ||
| Q3 24 | $-524.0M | $365.6M | ||
| Q2 24 | $1.1B | $371.9M |
| Q1 26 | 51.6% | — | ||
| Q4 25 | 42.4% | — | ||
| Q3 25 | 37.2% | — | ||
| Q2 25 | 54.6% | — | ||
| Q1 25 | 47.0% | — | ||
| Q4 24 | 37.3% | — | ||
| Q3 24 | 32.7% | — | ||
| Q2 24 | 52.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | -13.6% | 15.4% | ||
| Q3 25 | -14.1% | 17.2% | ||
| Q2 25 | 27.9% | 14.2% | ||
| Q1 25 | 17.7% | 15.2% | ||
| Q4 24 | 2.2% | 19.9% | ||
| Q3 24 | -27.2% | 14.0% | ||
| Q2 24 | 21.9% | 14.7% |
| Q1 26 | 14.7% | 14.0% | ||
| Q4 25 | -14.1% | 12.1% | ||
| Q3 25 | -12.2% | 13.6% | ||
| Q2 25 | 20.4% | 10.9% | ||
| Q1 25 | 14.8% | 11.8% | ||
| Q4 24 | -1.0% | 15.7% | ||
| Q3 24 | -22.5% | 10.8% | ||
| Q2 24 | 17.2% | 11.2% |
| Q1 26 | $1.07 | $1.31 | ||
| Q4 25 | $-0.80 | $1.13 | ||
| Q3 25 | $-0.47 | $1.28 | ||
| Q2 25 | $1.92 | $1.00 | ||
| Q1 25 | $0.95 | $1.04 | ||
| Q4 24 | $-0.05 | $0.89 | ||
| Q3 24 | $-0.76 | $0.91 | ||
| Q2 24 | $1.51 | $0.92 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.0B | $2.1B |
| Total DebtLower is stronger | $3.4B | — |
| Stockholders' EquityBook value | $24.6B | — |
| Total Assets | $42.7B | $44.3B |
| Debt / EquityLower = less leverage | 0.14× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $2.0B | $2.1B | ||
| Q4 25 | $4.5B | $2.5B | ||
| Q3 25 | $2.6B | $2.4B | ||
| Q2 25 | $2.1B | $2.0B | ||
| Q1 25 | $2.0B | $1.7B | ||
| Q4 24 | $3.2B | $2.0B | ||
| Q3 24 | $2.5B | $1.6B | ||
| Q2 24 | $2.0B | $1.6B |
| Q1 26 | $3.4B | — | ||
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.5B | — |
| Q1 26 | $24.6B | — | ||
| Q4 25 | $24.1B | $9.7B | ||
| Q3 25 | $25.2B | $9.8B | ||
| Q2 25 | $25.9B | $9.3B | ||
| Q1 25 | $24.3B | $8.9B | ||
| Q4 24 | $23.8B | $8.4B | ||
| Q3 24 | $24.7B | $8.4B | ||
| Q2 24 | $25.2B | $7.8B |
| Q1 26 | $42.7B | $44.3B | ||
| Q4 25 | $42.8B | $44.1B | ||
| Q3 25 | $42.2B | $43.7B | ||
| Q2 25 | $41.8B | $42.7B | ||
| Q1 25 | $42.1B | $41.3B | ||
| Q4 24 | $40.8B | $40.6B | ||
| Q3 24 | $41.9B | $40.4B | ||
| Q2 24 | $41.5B | $38.9B |
| Q1 26 | 0.14× | — | ||
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.07× | — | ||
| Q2 25 | 0.07× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.08× | — | ||
| Q3 24 | 0.08× | — | ||
| Q2 24 | 0.10× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
